Association of Treatment for Hodgkin Lymphoma With Estrogen Receptor Status of Subsequent Breast Cancers

Diana R Withrow; Lindsay M Morton; Rochelle E Curtis; Sara J Schonfeld; Amy Berrington de González

doi:10.1001/jamaoncol.2017.4887

Association of Treatment for Hodgkin Lymphoma With Estrogen Receptor Status of Subsequent Breast Cancers

JAMA Oncol. 2018 Mar 1;4(3):414-416. doi: 10.1001/jamaoncol.2017.4887.

Authors

Diana R Withrow¹, Lindsay M Morton¹, Rochelle E Curtis¹, Sara J Schonfeld¹, Amy Berrington de González¹

Affiliation

¹ Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland.

Abstract

This population-based cohort study examines the association of radiotherapy for Hodgkin lymphoma with risk of ER-positive and ER-negative breast cancers using data from the US National Cancer Institute Surveillance, Epidemiology, and End Results database.

Publication types

Letter

MeSH terms

Adolescent
Adult
Breast Neoplasms / epidemiology*
Breast Neoplasms / metabolism*
Cancer Survivors / statistics & numerical data
Child
Cohort Studies
Female
Hodgkin Disease / epidemiology*
Hodgkin Disease / radiotherapy*
Humans
Neoplasms, Radiation-Induced / epidemiology
Neoplasms, Radiation-Induced / metabolism
Neoplasms, Second Primary / epidemiology*
Neoplasms, Second Primary / metabolism*
Receptors, Estrogen / metabolism*
Risk Factors
SEER Program
United States / epidemiology
Young Adult

Substances

Receptors, Estrogen